Medication info

Adetan Tablets 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOralExpired
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Hanall Biopharma Co., Ltd.
Appearance
Pink round tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201005079 · Notified 2010.08.19

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time every day, regardless of meals. Essential hypertension - Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Essential hypertension - Elderly patients: No dose adjustment is necessary. Essential hypertension - Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. Essential hypertension - Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Essential hypertension - Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. Heart failure - Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased, according to the patient's tolerability, to a maximum of 32 mg once daily. Heart failure - Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No dose adjustment is necessary.
Child dose
Essential hypertension - Pediatric patients: The safety and efficacy of this medicine have not been established in adolescents and children 18 years of age or younger. Heart failure - Pediatric patients: The safety and efficacy of this medicine have not been established in adolescents and children 18 years of age or younger.

Ingredients

Manufacturer
Hanall Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • reduced left ventricular ejection fraction
View approved original text

This medication is used for the treatment of essential hypertension, effectively controlling blood pressure to help maintain cardiovascular health. It is also beneficial for patients with heart failure who have impaired left ventricular systolic function, particularly those requiring combination therapy with or alternative to ACE inhibitors. It helps alleviate symptoms of heart failure and improves cardiac function to support patients' daily lives. It is effectively used for the treatment of essential hypertension and heart failure.

How to take

Adult dose

This medicine should be taken at the same time every day, regardless of meals. Essential hypertension - Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Essential hypertension - Elderly patients: No dose adjustment is necessary. Essential hypertension - Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. Essential hypertension - Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Essential hypertension - Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. Heart failure - Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks and increased, according to the patient's tolerability, to a maximum of 32 mg once daily. Heart failure - Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No dose adjustment is necessary.

Child dose

Essential hypertension - Pediatric patients: The safety and efficacy of this medicine have not been established in adolescents and children 18 years of age or younger. Heart failure - Pediatric patients: The safety and efficacy of this medicine have not been established in adolescents and children 18 years of age or younger.

Precautions

This medication can cause severe harm to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It is safer for women who are pregnant, may become pregnant, or are breastfeeding to avoid this medication. People who are allergic to this drug or its components should not take it. Patients with very poor liver function or those with bile duct obstruction should not use this medication. Patients with a history of angioedema or hereditary angioedema should avoid this drug. Patients with primary hyperaldosteronism do not respond well to this medication, so it is advisable not to use it. Elderly patients, patients with hyperkalemia, patients with slightly impaired liver function, and those with heart valve disease or obstructive cardiomyopathy should use this medication cautiously. If ischemic heart disease or cerebrovascular disorders are present, caution is needed as excessively low blood pressure could pose risks of myocardial infarction or stroke. Patients with compromised kidney function or those who have recently undergone kidney transplantation should also be cautious of the risk of worsening renal function when using this medication. During the use of this medication, side effects such as dizziness, back pain, and respiratory infections may occur, and in rare cases, myalgia, rash, hematuria, and liver function abnormalities may also develop. Heart failure patients are at higher risk for side effects such as hypotension, hyperkalemia, and kidney function impairment, so it is important to regularly check potassium and creatinine levels through blood tests. This medication lowers blood pressure, so patients at risk of excessively low blood pressure or fainting should be cautious while taking it. When used together with other blood pressure medications or diuretics, side effects may increase due to interactions, so it's essential to consult a physician. In particular, caution should be exercised when used alongside potassium-sparing diuretics or potassium supplements as blood potassium levels may become dangerously elevated. Women who are pregnant or planning to become pregnant should avoid this medication, and it is recommended for breastfeeding women to discontinue breastfeeding while taking this medication. Safety in children and adolescents under 18 years of age has not been established, so use in these groups is not recommended. Elderly patients should be carefully monitored during administration as excessively low blood pressure can increase the risk of stroke and other complications. In case of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be kept out of reach of children and transferring it to another container may affect its quality, so caution is advised. Care should be taken when driving or operating machinery as dizziness or drowsiness may occur.

Side effects

  • Dizziness
  • low back pain
  • respiratory infection
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • weakness
  • fever
  • sensory disturbances
  • indigestion
Show 66 more
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • kidney function impairment
  • increased creatinine
  • increased urea
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • increased liver enzymes
  • hepatitis
  • elevated AST
  • elevated ALT
  • increased γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • tension hypertonia
  • syncope
  • facial flushing
  • weight gain
  • facial edema
  • polydipsia
  • sleep disturbances
  • decreased libido
  • amnesia
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. Additionally, it should be kept at room temperature between 1 to 30 degrees Celsius, rather than in excessively hot or cold places.

Appearance and packaging

Appearance

Pink round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.